141 related articles for article (PubMed ID: 6605803)
1. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancers.
Watanabe S; Sato Y; Kodama T; Shimosato Y
Cancer Res; 1983 Dec; 43(12 Pt 1):5883-9. PubMed ID: 6605803
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical characterization of lymphocytes and histiocytes in bladder cancers in terms of local immune responses].
Hanai S; Shimosato Y; Watanabe S; Sato Y; Kishi K; Kakizoe T; Matsumoto K
Gan No Rinsho; 1985 Jun; 31(7):839-46. PubMed ID: 2411967
[TBL] [Abstract][Full Text] [Related]
3. [The expression of monoclonal antibody KM-93 reactive antigen in human lung carcinoma--an immunohistochemical evaluation].
Sasaki K; Matsumura K; Ogino T; Tsuji T; Shinozaki F; Takahashi M
Gan No Rinsho; 1988 Jul; 34(8):965-8. PubMed ID: 2457119
[TBL] [Abstract][Full Text] [Related]
4. [Cytotoxicity of lymphocytes against autologous cultured primary lung cancer cells in relation to histological type and clinical stage].
Kimura H; Yamaguchi Y; Kadoyama C; Matsumoto A
Gan To Kagaku Ryoho; 1986 Jun; 13(6):2175-81. PubMed ID: 3013100
[TBL] [Abstract][Full Text] [Related]
5. An immunohistochemical study of lung carcinomas using a monoclonal antibody which specifically reacts to basal cells.
Maeda K; Sueishi K
Mod Pathol; 1990 Jan; 3(1):43-8. PubMed ID: 2155419
[TBL] [Abstract][Full Text] [Related]
6. Expression of epithelial and neural antigens in small cell and non small cell lung carcinoma.
Moss F; Bobrow LG; Sheppard MN; Griffiths M; Rowe D; Beverley PC; Addis B; Souhami RL
J Pathol; 1986 Jun; 149(2):103-11. PubMed ID: 2426429
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical studies on the expression of pulmonary surfactant apoproteins in human lung carcinomas using monoclonal antibodies.
Dempo K; Satoh M; Tsuji S; Mori M; Kuroki Y; Akino T
Pathol Res Pract; 1987 Oct; 182(5):669-75. PubMed ID: 2825147
[TBL] [Abstract][Full Text] [Related]
8. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of histiocytes in primary lung cancer stained with anti-S100 protein, lysozyme and OKT 6 antibodies.
Furukawa T; Watanabe S; Sato Y; Kodama T; Nakajima T; Shimosato Y
Jpn J Clin Oncol; 1984 Dec; 14(4):647-57. PubMed ID: 6084077
[TBL] [Abstract][Full Text] [Related]
10. In situ subpopulations of lymphocytes in human colorectal carcinomas.
Lennard TW; Warford A; Taylor RM; Shenton BK; Proud G
Invasion Metastasis; 1984; 4 Suppl 1():60-6. PubMed ID: 6241931
[TBL] [Abstract][Full Text] [Related]
11. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
[TBL] [Abstract][Full Text] [Related]
12. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours.
Mayall FG; Gibbs AR
J Pathol; 1991 May; 164(1):47-50. PubMed ID: 1647450
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
Brenner BG; Jothy S; Shuster J; Fuks A
Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray evaluation of Melanoma antigen E (MAGE) tumor-associated antigen expression: potential indications for specific immunotherapy and prognostic relevance in squamous cell lung carcinoma.
Bolli M; Kocher T; Adamina M; Guller U; Dalquen P; Haas P; Mirlacher M; Gambazzi F; Harder F; Heberer M; Sauter G; Spagnoli GC
Ann Surg; 2002 Dec; 236(6):785-93; discussion 793. PubMed ID: 12454517
[TBL] [Abstract][Full Text] [Related]
15. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
16. [Use of monoclonal antibodies for immunodiagnosis of lung cancer].
Romanova RI; Gergert VI; Filippov VP; Goncharskaia MA; Evgushchenko GV; Sidorova NF; Gorelova LA
Probl Tuberk; 1997; (5):44-8. PubMed ID: 9454255
[TBL] [Abstract][Full Text] [Related]
17. Bronchial carcinoma and its regional lymph nodes in relation to immunological functions.
Syrjänen KJ
Z Immunitatsforsch Immunobiol; 1979 Feb; 155(3):212-22. PubMed ID: 311556
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
19. Soluble proteins of human bronchogenic carcinomas.
Granlund DJ; Ritts RE
Mayo Clin Proc; 1976 Jan; 51(1):19-27. PubMed ID: 765635
[TBL] [Abstract][Full Text] [Related]
20. Comparative T-cell oligoclonality in lung, tumor and lymph nodes in human non-small cell lung cancer.
Derniame S; Vignaud JM; Faure GC; Béné MC; Massin F
Oncol Rep; 2005 Mar; 13(3):509-15. PubMed ID: 15706426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
